XML 40 R26.htm IDEA: XBRL DOCUMENT

Revenues (Tables)

9 Months Ended

Sep. 30, 2021

Revenues

Schedule of disaggregated revenue

As discussed in Note 2, revenues are recognized under guidance within ASC 606. The following table presents our disaggregated revenue for the periods presented (in thousands):


		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2021			2020			2021			2020
JAKAFI revenues, net		$	547,373		$	487,783		$	1,542,138		$	1,420,968
ICLUSIG revenues, net			28,522			26,380			82,356			76,426
PEMAZYRE revenues, net			17,562			8,089			48,924			11,875
MINJUVI revenues, net			556			—			556			—
Total product revenues, net			594,013			522,252			1,673,974			1,509,269
JAKAVI product royalty revenues			94,655			68,306			242,295			190,856
OLUMIANT product royalty revenues			86,572			28,647			154,875			79,924
TABRECTA product royalty revenues			2,747			1,438			7,270			2,144
Total product royalty revenues			183,974			98,391			404,440			272,924
Milestone and contract revenues			35,000			—			45,000			95,000
Total revenues		$	812,987		$	620,643		$	2,123,414		$	1,877,193